Our respected client, Arineta Ltd., a leader in advancing cardiovascular imaging solutions through cutting-edge technology, announces a significant breakthrough in its “go to China” activities, with the signing of a cooperation agreement on the establishment of a joint venture company to be based in Jinan Medical Center, located in the city of Jinan, the capital of Shandong Province of China.
The new joint venture company, Arineta (Shandong) Medical Co. Ltd., a cooperation between Arineta Ltd. and Shandong Yituo Medical Technology Development Co. Ltd. (SYMT), a JMC invested company.
The signing ceremony was held in Jinan on Tuesday (17/4). Signing on the agreement were Mr. Wen QingYong, the Chairman of Shandong Yituo Medical Technology Development Co. Ltd. and Mr. Doug Ryan, CEO of Arineta Ltd. and the Chairman of the new JV Company.
The signing event was honored with the presence of H.E. the Ambassador of Israel to China, Ms. Irit Ben-Abba, Ms. Lei Jie, the Chairwoman of the Jinan CPPCC & Head of the Jinan Medical Center; Mr. Meng XiangDong, Chairman of Shandong CCPIT; Ms. Yang Li, Vice Mayor of Jinan, Mr. Sun Changjian, Secretary of Huaiyin District Committee and Secretary of the Party Working Committee of JMC; Liu Ruiling, Director of Jinan Foreign Affairs Office; Mr. Zhang Ji, Director of the Management Committee of JMC; Mr. Xu Lei, Deputy Director of Jinan Industry & IT Bureau; Mr. Li Jianhua, Deputy Director of JMC; Li Huabing, the Director of FOCOC; Mr. Ma Ning, the Chairman of JMC Industrial Development Co.; and other dignitaries.
The event was also joined by Mr. Tie Fei, the CEO of SYMT and the CEO of the new JV Company, Mr. Einav Ehra, the CFO of Arineta and of the new JV Company, as well as Mr. Ilan Maor, the Managing Partner of SHENG Enterprises and Ms. Ma ZiYan, Manager in SHENG, Arineta’s advisory firm.
Speaking at the signing event and the following dinner, Ambassador Ben-Abba, Chairwoman Lei JIe, and Vice Mayor Yang Li have all expressed their strong support to the new JV Company!
Arineta (Shandong) Medical Co. will immediately initiate the registration process of the Arineta’s SpotLight™ Duo with the National Medical Products Administration (NMPA), as well as initiate the domestically assembly site, to support the growing need to ultra-premium cardio CT in China.
The planned introduction of the SpotLight™ Duo in China is expected to make a significant contribution to the medical care provided to cardio and lung patients in China. “For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta’s patient centric technologies. With one heartbeat, we can provide both high-temporal as well as iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment,” said Doug Ryan, CEO of Arineta and the Chairman of the new JV Company. “At the same time, we are reducing radiation and contrast for scans while delivering more detailed and accurate images for better informed decision-making by physicians.”
The FDA-cleared SpotLight™ Duo provides the single beat, whole heart scanner is optimized with 140 mm coverage at a rotation speed of 0.24 sec per rotation. Its deep-learning imaging reconstruction (DLIR) technology provides improved image quality by reconstructing cross-sectional images of the subject, allowing for a more complete and accurate CT scan. The SpotLight™ Duo adds also high resolution thoracic clinical capabilities for lung cancer and other pulmonary diseases to its cardiovascular CT technology.
Installation of the first SpotLight™ Duo, the highest performance cardiovascular and thoracic CT scanner in the industry in a major health system is expected to be made in a leading hospital in Jinan, within a couple of months, supporting the clinical trials and the NMPA registration process.
About Arineta:
Arineta is an Israeli company that develops and produces innovative cardiovascular imaging solutions. It is dedicated to growing cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease, the no. 1 cause of death and costs for healthcare worldwide. Arineta’s flagship product, SpotLight™ Duo, is the world’s first dedicated single-heartbeat, whole-heart cardiovascular and thoracic CT, based on the company’s proprietary Stereo CT technology. The company is part of a long tradition of medical imaging innovation that began in Israel in the 1970s. Among Arineta’s scientists are the inventors of the multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies. For more information, please visit: www.arineta.com.
About the Jinan Medical Center (JMC):
The Jinan Medical Center was established in July 2017 with the approval of the Shandong Provincial Government approval. Located in West Jinan, it covers an area of 35 square kilometers, with planned construction area of 27 million square meters and total investment of close to 28 billion USD. The JMC is following the American Medical Center model – generating the healthcare and medical silicon valley, integrating leading academic and research institutes, public & private hospitals, as well as technological innovation and industrial production.